Hans Petter Tjeldflaat
Plus aucun poste en cours
Profil
Hans Petter Tjeldflaat worked as a Finance Director at Affitech.
AS from 2006 to 2009.
He also worked as an Investment Manager at SND Invest AS and as the Head-Investor Relations at Christiania Bank Og Kreditkasse.
He served as the Chief Financial Officer at Inovio AS, Nykode Therapeutics ASA, Nextera AS, Otivio AS, Nordic Nanovector ASA, and RespiNor AS.
Tjeldflaat graduated from the University of Wisconsin with a graduate degree and also holds a graduate degree from the Norwegian School of Economics & Business Administration.
Anciens postes connus de Hans Petter Tjeldflaat
| Sociétés | Poste | Fin |
|---|---|---|
Affitech AS /Old/
 Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Directeur Financier/CFO | 16/06/2009 |
| Christiania Bank Og Kreditkasse | Investor Relations Contact | - |
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Directeur Financier/CFO | - |
RespiNor AS
 RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Directeur Financier/CFO | - |
Otivio AS
 Otivio AS Medical SpecialtiesHealth Technology Otivio AS manufactures non-invasive medical devices. The private company is based in Oslo, Norway. | Directeur Financier/CFO | - |
Formation de Hans Petter Tjeldflaat
| University of Wisconsin | Graduate Degree |
| Norwegian School of Economics & Business Administration | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NYKODE THERAPEUTICS | Health Technology |
| Entreprise privées | 8 |
|---|---|
| SND Invest AS | Finance |
| Christiania Bank Og Kreditkasse | Finance |
| Inovio AS | Health Technology |
Affitech AS /Old/
Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Affitech AS discovers and develops human therapeutic antibodies. It focuses on molecule and cell based antibody discovery. The company was founded by Martin Welschof, Ole Jorgen Marvik, and Michael Braunagel in 1997 and is headquartered in Oslo, Norway. | Commercial Services |
Nextera AS
Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Commercial Services |
Otivio AS
Otivio AS Medical SpecialtiesHealth Technology Otivio AS manufactures non-invasive medical devices. The private company is based in Oslo, Norway. | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
RespiNor AS
RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |
